Screen Reader Mode Icon

Thank You for Joining Us!

Please complete the following evaluation to claim your credit for The Lipid Panel webcast presented on May 29, 2024.

Question Title

* 1. Please Complete the following

Question Title

* 2. What is your area of specialization?

Question Title

* 3. How long have you been in practice?

Question Title

* 4. How many patients with dyslipidemia do you currently see each week?

Question Title

* 5. Please mark your response to the following questions:
After participating in this activity, I am able to:

  1- Strongly Disagree 2- Disagree 3- Neutral 4- Agree 5- Strongly Agree
Discuss strategies for the management of patients with lipid disorders.
Recognize the prevalence of triglyceride-rich remnant lipoproteins in ASCVD.
Discuss treatment options for hypertriglyceridemia, both for primary and secondary prevention of cardiovascular events in patients with ASCVD.
Outline appropriate therapy options for high CVD risk patients with elevated triglyceride levels.
Identify the clinical and genetic attributes, available diagnostic tools, and screening practices to aid the identification of individuals with chylomicronemia syndrome.
Explain the role of genetic testing in the identification of familial chylomicronemia syndrome (FCS) and multifactorial chylomicronemia (MCM).
Outline appropriate therapy options for patients with chylomicronemia syndrome and multifactorial chylomicronemia.
Discuss strategies to improve the knowledge, skills, or performance of the healthcare team.

Question Title

* 6. Please mark your response to the following questions:
Rate your level of agreement with the statement(s) below:

  1- Strongly Disagree 2- Disagree 3- Neutral 4- Agree 5- Strongly Agree
My opportunity for learning assessment was appropriate to the activity.
The content presented enhanced my current knowledge base.
The content presented was scientifically rigorous and evidence-based.
The scope, depth, and level of content were appropriate.
The invitation accurately conveyed the purpose and content.
The activities (e.g. faculty questions/discussion, case studies) provided appropriate and effective opportunities for active learning.
The activity promoted improvements of quality in health care.

Question Title

* 7. Was this activity fair and balanced?

Question Title

* 8. Did the activity avoid commercial bias or influence?

Question Title

* 9. The faculty provided a disclosure and disclosed any off-label/investigational use of products discussed before the start of the activity.

Question Title

* 10. As a result of participating in this activity, what will you do differently to improve the care of your patients?

Question Title

* 11. Select the one option below that most applies with this statement: Based upon my participation in this activity, I:

Question Title

* 12. If you gained new strategies, skills, and/or information that you plan to implement into your practice, what types of changes do you plan to implement?

Question Title

* 13. What barriers do you see to implementing these changes in your practice?

Question Title

* 14. Please provide any additional comments related to the activity in the space below.

Question Title

* 15. Please indicate the type of credit you are claiming

T